Michael Firer

Michael Firer

Apr 18, 2022

Group 6 Copy 10
0
    Please wait...

    About This Project

    Anti-Phospholipid Syndrome (APS) is an autoimmune disease in which certain antibodies cause blood clotting. These antibodies are an important cause of spontaneous miscarriage in women aged 20-50 years. There is no effective treatment for APS. Our project will test whether small peptides we have discovered, can block the activity of these antibodies. Positive results from these experiments will support further development of the peptides as a new therapy for APS.

    More Lab Notes From This Project

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

    We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

    The Dogs of Chernobyl Research Initiative

    The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...

    Which Human Physical Aging Biomarkers Validate Genetic and Biochemical Aging Reversal Success?

    Harvard Medical School has reported successful aging reversal using genetic and biochemical methods in the...